---
title: Clobetasol + Lactic Acid + Salicylic Acid + Urea
description: >-
  This combination medication is primarily prescribed for inflammatory skin
  conditions, especially those characterized by dryness, scaling, and
  thickening.  It is particularly effective for treating:
is_banned: false
lastModified: '2025-09-22T17:22:08.847Z'
faqs:
  - q: >-
      What is the recommended dosage for Clobetasol + Lactic Acid + Salicylic
      Acid + Urea?**


      **A:** Apply a thin layer to affected areas 1-2 times daily.  Maximum
      50g/week.  Consult a physician for precise duration and adjustment based
      on individual needs.
    a: >-
      A:** Apply a thin layer to affected areas 1-2 times daily.  Maximum
      50g/week.  Consult a physician for precise duration and adjustment based
      on individual needs.
  - q: >-
      Can I use this combination on my face?**


      **A:**  Use on the face with extreme caution and only under the close
      supervision of a dermatologist.  The skin on the face is more sensitive
      and prone to adverse effects like atrophy.
    a: >-
      A:**  Use on the face with extreme caution and only under the close
      supervision of a dermatologist.  The skin on the face is more sensitive
      and prone to adverse effects like atrophy.
  - q: >-
      What should I do if I experience burning or stinging after application?**


      **A:** Discontinue use and consult your physician.  It might indicate
      irritation or an allergic reaction.
    a: >-
      A:** Discontinue use and consult your physician.  It might indicate
      irritation or an allergic reaction.
  - q: >-
      Can I use this medication during pregnancy or breastfeeding?**


      **A:**  Safety is not well established.  Consult your physician before
      use.
    a: 'A:**  Safety is not well established.  Consult your physician before use.'
  - q: >-
      How long can I use this medication continuously?**


      **A:**  Generally, not more than 2 consecutive weeks. For localized
      psoriasis, a physician may extend use for up to 2 additional weeks if no
      improvement after the initial two weeks.
    a: >-
      A:**  Generally, not more than 2 consecutive weeks. For localized
      psoriasis, a physician may extend use for up to 2 additional weeks if no
      improvement after the initial two weeks.
  - q: >-
      Is it safe to use this medication with other topical treatments?**


      **A:**  It can potentially interact with other topical medications. Inform
      your physician about all other topical products you are using.
    a: >-
      A:**  It can potentially interact with other topical medications. Inform
      your physician about all other topical products you are using.
  - q: >-
      What are the signs of skin atrophy?**


      **A:** Skin thinning, fragility, easy bruising, telangiectasia (spider
      veins), and hypopigmentation.
    a: >-
      A:** Skin thinning, fragility, easy bruising, telangiectasia (spider
      veins), and hypopigmentation.
  - q: >-
      Can this medication affect blood glucose levels?**


      **A:** Yes, clobetasol can potentially affect blood glucose. Monitor
      levels carefully, especially if you have diabetes.
    a: >-
      A:** Yes, clobetasol can potentially affect blood glucose. Monitor levels
      carefully, especially if you have diabetes.
  - q: >-
      Can I cover the treated area with a bandage?**


      **A:** Avoid using occlusive dressings unless specifically directed by a
      physician, as this can significantly enhance clobetasol absorption and
      increase the risk of systemic side effects.
    a: >-
      A:** Avoid using occlusive dressings unless specifically directed by a
      physician, as this can significantly enhance clobetasol absorption and
      increase the risk of systemic side effects.
  - q: >-
      Can I use this on open wounds or cuts?**


      **A:** No. Apply only to intact skin. Avoid application on open wounds or
      cuts.
    a: >-
      A:** No. Apply only to intact skin. Avoid application on open wounds or
      cuts.
---
## **Usage**

This combination medication is primarily prescribed for inflammatory skin conditions, especially those characterized by dryness, scaling, and thickening.  It is particularly effective for treating:

* **Eczema:** A group of conditions causing inflamed, itchy, red, cracked, and rough skin.
* **Psoriasis:** An autoimmune disease causing rapid skin cell buildup, resulting in red, bumpy patches with white scales.
* **Corns and calluses:** Thickened areas of skin caused by pressure or friction.
* **Other hyperkeratotic skin conditions:** Such as ichthyosis and lichen planus.

This drug's pharmacological classifications include:

* **Corticosteroid (Clobetasol):**  Provides potent anti-inflammatory and antipruritic (anti-itch) effects.
* **Keratolytic (Salicylic Acid & Urea):**  Softens and breaks down keratin, facilitating exfoliation of dead skin cells.
* **Humectant (Urea & Lactic Acid):** Attracts and retains moisture, hydrating the skin.

## **Alternate Names**

There isn't a universally recognized alternate name for this specific combination.  However, each individual component has synonyms:

* **Clobetasol:** Clobetasol propionate
* **Lactic Acid:**  No common synonyms.
* **Salicylic Acid:**  No common synonyms.
* **Urea:** Carbamide

Brand names can vary significantly by region. Examples from India include:
* Clobavin-S
* Dermiedge-MF
* COVATE-MF
* Abronate-NF


## **How It Works**

**Pharmacodynamics:**

* **Clobetasol:**  Binds to glucocorticoid receptors in skin cells, suppressing the inflammatory response by inhibiting the production of prostaglandins and other inflammatory mediators. This reduces redness, swelling, and itching.
* **Salicylic Acid:**  Increases skin hydration and dissolves the intercellular "cement" holding keratinocytes together. This loosens the stratum corneum, promoting shedding of dead skin cells and softening thickened plaques.
* **Urea:**  Breaks down hydrogen bonds between keratin molecules, increasing water absorption by the stratum corneum and improving skin hydration. It also possesses mild keratolytic properties.
* **Lactic Acid:**  Is a naturally occurring alpha-hydroxy acid (AHA) that exfoliates skin by loosening the bonds between dead skin cells. It also acts as a humectant.

**Pharmacokinetics:**

* **Clobetasol:** Topically applied clobetasol has minimal systemic absorption when used as directed. A small amount may be metabolized in the skin and liver, ultimately excreted by the kidneys.
* **Salicylic Acid:** Percutaneous absorption is relatively low, primarily excreted by the kidneys.
* **Urea:**  Mostly stays within the stratum corneum; minimal systemic absorption when used on intact skin.
* **Lactic Acid:** Minimally absorbed systemically.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

Apply a thin layer to the affected area 1-2 times daily. The exact frequency and duration of therapy should be determined by a physician based on the severity and type of skin condition. Do not exceed 50g/week.

#### **Children:**

Use in children under 12 years of age is generally not recommended for this combination product, except under the careful supervision of a physician. For individual components like salicylic acid, age-specific dosing guidelines exist.


#### **Special Cases:**

* **Elderly Patients:** Similar to adults but monitor closely for skin thinning.
* **Patients with Renal Impairment:** Caution advised; potential for increased systemic absorption of clobetasol.
* **Patients with Hepatic Dysfunction:**  Caution advised; potential for altered clobetasol metabolism.
* **Patients with Comorbid Conditions:**  Individualized assessment is necessary, especially for diabetes (clobetasol can affect blood glucose levels).

### **Clinical Use Cases**  

This combination is not typically used in clinical settings like intubation, surgical procedures, mechanical ventilation, ICU, or emergency situations. It is designed for topical treatment of dermatological conditions.


### **Dosage Adjustments**  

Dose modifications are based on individual patient factors, severity of the condition, and response to treatment.  Patients with renal or hepatic impairment may require lower doses or closer monitoring.


## **Side Effects**

### **Common Side Effects**

* Burning or stinging sensation at the application site
* Itching
* Redness
* Dryness
* Peeling or flaking skin

### **Rare but Serious Side Effects**

* Skin atrophy (thinning)
* Telangiectasia (spider veins)
* Hypopigmentation (skin lightening)
* Hypertrichosis (increased hair growth)
* Allergic contact dermatitis
* Systemic absorption of clobetasol (leading to adrenal suppression in rare cases)

### **Long-Term Effects**

* Skin atrophy
* Striae (stretch marks)
* Telangiectasia

### **Adverse Drug Reactions (ADR)**

* Severe allergic reactions (anaphylaxis)
* Cushing's syndrome (due to systemic absorption of clobetasol)


## **Contraindications**

* Hypersensitivity to any of the components.
* Active bacterial, viral, or fungal skin infections at the application site.
* Rosacea.
* Acne vulgaris.
* Perioral dermatitis.

## **Drug Interactions**

* Other topical medications, especially those containing AHAs or other keratolytics, can increase irritation or enhance absorption of clobetasol.
* Systemic corticosteroids may increase the risk of adverse effects from clobetasol.


## **Pregnancy and Breastfeeding**

* **Pregnancy:**  Safety not well established.  Use only if clearly needed and under close medical supervision.
* **Breastfeeding:**  Safety not well established.  Use with caution and avoid applying to areas that may come into contact with the infant.

## **Drug Profile Summary**

* **Mechanism of Action:** Clobetasol: Anti-inflammatory and antipruritic; Salicylic Acid and Urea: Keratolytic; Lactic Acid and Urea: Humectant.
* **Side Effects:** Burning, stinging, itching, redness, dryness, peeling.  Rarely, skin atrophy, telangiectasia.
* **Contraindications:** Hypersensitivity, active skin infections, rosacea, acne, perioral dermatitis.
* **Drug Interactions:**  Other topical medications, systemic corticosteroids.
* **Pregnancy & Breastfeeding:**  Use with caution if clearly needed.
* **Dosage:** Apply thinly 1-2 times daily. Do not exceed 50g/week.
* **Monitoring Parameters:**  Skin condition, signs of local or systemic side effects, blood glucose (in diabetic patients).

## **Popular Combinations**

This specific combination is already a popular formulation.  If a secondary bacterial or fungal infection is present, a physician may add an antimicrobial agent.

## **Precautions**

* Avoid contact with eyes and mucous membranes.
* Do not use on broken or infected skin.
* Avoid prolonged use and application to large areas of skin.
* Use with caution in patients with diabetes, as clobetasol can affect blood glucose levels.
* Monitor for signs of skin atrophy or other adverse effects.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Clobetasol + Lactic Acid + Salicylic Acid + Urea?**

**A:** Apply a thin layer to affected areas 1-2 times daily.  Maximum 50g/week.  Consult a physician for precise duration and adjustment based on individual needs.

### **Q2: Can I use this combination on my face?**

**A:**  Use on the face with extreme caution and only under the close supervision of a dermatologist.  The skin on the face is more sensitive and prone to adverse effects like atrophy.

### **Q3: What should I do if I experience burning or stinging after application?**

**A:** Discontinue use and consult your physician.  It might indicate irritation or an allergic reaction.

### **Q4:  Can I use this medication during pregnancy or breastfeeding?**

**A:**  Safety is not well established.  Consult your physician before use.

### **Q5: How long can I use this medication continuously?**

**A:**  Generally, not more than 2 consecutive weeks. For localized psoriasis, a physician may extend use for up to 2 additional weeks if no improvement after the initial two weeks.  

### **Q6: Is it safe to use this medication with other topical treatments?**

**A:**  It can potentially interact with other topical medications. Inform your physician about all other topical products you are using.

### **Q7: What are the signs of skin atrophy?**

**A:** Skin thinning, fragility, easy bruising, telangiectasia (spider veins), and hypopigmentation.

### **Q8: Can this medication affect blood glucose levels?**

**A:** Yes, clobetasol can potentially affect blood glucose. Monitor levels carefully, especially if you have diabetes.

### **Q9: Can I cover the treated area with a bandage?**

**A:** Avoid using occlusive dressings unless specifically directed by a physician, as this can significantly enhance clobetasol absorption and increase the risk of systemic side effects.

### **Q10: Can I use this on open wounds or cuts?**

**A:** No. Apply only to intact skin. Avoid application on open wounds or cuts.

